Valeur20212022202320242025TTMFlux de trésorerie liés aux activités d'investissement-12.91 M-5.75 M-5.41 M-892 K416 K476 KFlux de trésorerie liés aux activités de financement222.74 M325 K1.87 M2.16 M2 0000Flux de trésorerie disponible-32.58 M-14.43 M-50.92 M-28.94 M-48.02 M-36.48 M
Barinthus Biotherapeutics plc - American Depositary Shares
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.